179 related articles for article (PubMed ID: 11250752)
1. The cyclin dependent kinase inhibitor p27 and its prognostic role in breast cancer.
Chiarle R; Pagano M; Inghirami G
Breast Cancer Res; 2001; 3(2):91-4. PubMed ID: 11250752
[TBL] [Abstract][Full Text] [Related]
2. Prognostic impact of cyclin-dependent kinase inhibitor p27kip1 in node-positive breast cancer.
Tsuchiya A; Zhang GJ; Kanno M
J Surg Oncol; 1999 Apr; 70(4):230-4. PubMed ID: 10219018
[TBL] [Abstract][Full Text] [Related]
3. Cyclin-dependent kinase inhibitor p27Kip1 expression and interaction with other cell cycle-associated proteins in mammary carcinoma.
Gillett CE; Smith P; Peters G; Lu X; Barnes DM
J Pathol; 1999 Jan; 187(2):200-6. PubMed ID: 10365095
[TBL] [Abstract][Full Text] [Related]
4. Prognostic value of p27(Kip1) and CyclinD1 expression in esophageal cancer.
Itami A; Shimada Y; Watanabe G; Imamura M
Oncology; 1999 Nov; 57(4):311-7. PubMed ID: 10575318
[TBL] [Abstract][Full Text] [Related]
5. p27 expression as a prognostic factor of breast cancer in Taiwan.
Chu JS; Huang CS; Chang KJ
Cancer Lett; 1999 Jul; 141(1-2):123-30. PubMed ID: 10454252
[TBL] [Abstract][Full Text] [Related]
6. p27 Expression, a cyclin dependent kinase inhibitor in breast carcinoma.
Barbareschi M
Adv Clin Path; 1999 Oct; 3(4):119-27. PubMed ID: 10936889
[TBL] [Abstract][Full Text] [Related]
7. The cell cycle inhibitor p27 is an independent prognostic marker in small (T1a,b) invasive breast carcinomas.
Tan P; Cady B; Wanner M; Worland P; Cukor B; Magi-Galluzzi C; Lavin P; Draetta G; Pagano M; Loda M
Cancer Res; 1997 Apr; 57(7):1259-63. PubMed ID: 9102210
[TBL] [Abstract][Full Text] [Related]
8. p21, p27, cyclin D1, and p53 in rectal cancer: immunohistology with prognostic significance?
Schwandner O; Bruch HP; Broll R
Int J Colorectal Dis; 2002 Jan; 17(1):11-9. PubMed ID: 12018448
[TBL] [Abstract][Full Text] [Related]
9. Prognostic significance of p27Kip1 and Ki-67 expression in carcinoma of the renal pelvis and ureter.
Kamai T; Takagi K; Asami H; Ito Y; Arai K; Yoshida KI
BJU Int; 2000 Jul; 86(1):14-9. PubMed ID: 10886076
[TBL] [Abstract][Full Text] [Related]
10. High level expression of p27(kip1) and cyclin D1 in some human breast cancer cells: inverse correlation between the expression of p27(kip1) and degree of malignancy in human breast and colorectal cancers.
Fredersdorf S; Burns J; Milne AM; Packham G; Fallis L; Gillett CE; Royds JA; Peston D; Hall PA; Hanby AM; Barnes DM; Shousha S; O'Hare MJ; Lu X
Proc Natl Acad Sci U S A; 1997 Jun; 94(12):6380-5. PubMed ID: 9177226
[TBL] [Abstract][Full Text] [Related]
11. Low p27 expression predicts poor disease-free survival in patients with prostate cancer.
Yang RM; Naitoh J; Murphy M; Wang HJ; Phillipson J; deKernion JB; Loda M; Reiter RE
J Urol; 1998 Mar; 159(3):941-5. PubMed ID: 9474188
[TBL] [Abstract][Full Text] [Related]
12. Differential expression of p16/p21/p27 and cyclin D1/D3, and their relationships to cell proliferation, apoptosis, and tumour progression in invasive ductal carcinoma of the breast.
Wong SC; Chan JK; Lee KC; Hsiao WL
J Pathol; 2001 May; 194(1):35-42. PubMed ID: 11329139
[TBL] [Abstract][Full Text] [Related]
13. Prognostic implication of cyclin E expression and its relationship with cyclin D1 and p27Kip1 expression on tissue microarrays of node negative breast cancer.
Han S; Park K; Bae BN; Kim KH; Kim HJ; Kim YD; Kim HY
J Surg Oncol; 2003 Aug; 83(4):241-7. PubMed ID: 12884237
[TBL] [Abstract][Full Text] [Related]
14. ErbB2/neu kinase modulates cellular p27(Kip1) and cyclin D1 through multiple signaling pathways.
Lenferink AE; Busse D; Flanagan WM; Yakes FM; Arteaga CL
Cancer Res; 2001 Sep; 61(17):6583-91. PubMed ID: 11522658
[TBL] [Abstract][Full Text] [Related]
15. Correlation of p27 protein expression with HER-2/neu expression in breast cancer.
Newman L; Xia W; Yang HY; Sahin A; Bondy M; Lukmanji F; Hung MC; Lee MH
Mol Carcinog; 2001 Mar; 30(3):169-75. PubMed ID: 11301477
[TBL] [Abstract][Full Text] [Related]
16. Loss of cell cycle regulators p27(Kip1) and cyclin E in transitional cell carcinoma of the bladder correlates with tumor grade and patient survival.
Del Pizzo JJ; Borkowski A; Jacobs SC; Kyprianou N
Am J Pathol; 1999 Oct; 155(4):1129-36. PubMed ID: 10514396
[TBL] [Abstract][Full Text] [Related]
17. Expression and prognostic roles of the G1-S modulators in hepatocellular carcinoma: p27 independently predicts the recurrence.
Ito Y; Matsuura N; Sakon M; Miyoshi E; Noda K; Takeda T; Umeshita K; Nagano H; Nakamori S; Dono K; Tsujimoto M; Nakahara M; Nakao K; Taniguchi N; Monden M
Hepatology; 1999 Jul; 30(1):90-9. PubMed ID: 10385644
[TBL] [Abstract][Full Text] [Related]
18. Loss or altered subcellular localization of p27 in Barrett's associated adenocarcinoma.
Singh SP; Lipman J; Goldman H; Ellis FH; Aizenman L; Cangi MG; Signoretti S; Chiaur DS; Pagano M; Loda M
Cancer Res; 1998 Apr; 58(8):1730-5. PubMed ID: 9563491
[TBL] [Abstract][Full Text] [Related]
19. Decreased p27(Kip1) expression and cyclin D1 overexpression, alone and in combination, influence recurrence and survival of patients with resectable extrahepatic bile duct carcinoma.
Hui AM; Cui X; Makuuchi M; Li X; Shi YZ; Takayama T
Hepatology; 1999 Nov; 30(5):1167-73. PubMed ID: 10534337
[TBL] [Abstract][Full Text] [Related]
20. Clinical relevance of expression of the CIP/KIP cell-cycle inhibitors p21 and p27 in laryngeal cancer.
Pruneri G; Pignataro L; Carboni N; Buffa R; Di Finizio D; Cesana BM; Neri A
J Clin Oncol; 1999 Oct; 17(10):3150-9. PubMed ID: 10506612
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
